4CMenB vaccineMeSH Supplementary Concept

https://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/soliris-bexsero-fra.php
2016
false
false
false
Canada
French
pharmacovigilance note
educational measurement
hemoglobins
vaccinia
risk assessment
vaccination, nos
4CMenB vaccine
neisseria meningitidis
plural
eculizumab
hemoglobin a2prime
has patient
vaccination
vaccine, nos
hemoglobin, nos
hemolysis, nos
hemolysis
asthenia
vaccines
hemoglobin a2
treaties
vaccinia, nos
eculizumab
hemoglobin a3
patients
meningococcus vaccination
vaccinia
international cooperation
meningococcal vaccines
antibodies, monoclonal, humanized

---
http://kce.fgov.be/fr/publication/report/un-vaccin-quadrivalent-contre-le-m%C3%A9ningocoque-de-groupe-b-analyse-co%C3%BBt-efficacit%C3%A9
https://kce.fgov.be/sites/default/files/2021-12/KCE_231Bs_Meningocoque%20B_Synthese.pdf
2014
false
false
false
Belgium
French
meningococcal vaccines
Cost-Benefit analysis
neisseria meningitidis, serogroup B
technical report
4CMenB vaccine
infant
adolescent
economic evaluation
meningococcal vaccines
treatment outcome
carrier state
antibiotic therapy

---
http://www.phac-aspc.gc.ca/naci-ccni/mening-4cmenb-exec-resum-fra.php
2014
Canada
French
meningococcal vaccines
meningococcal infections
public health guidelines
neisseria meningitidis, serogroup B
4CMenB vaccine

---
http://www.has-sante.fr/portail/jcms/c_1753524/fr/bexsero
2014
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
vaccination
injections, intramuscular
meningococcal vaccines
meningococcal vaccines
meningococcal infections
neisseria meningitidis, serogroup B
insurance, health, reimbursement
meningococcus B, multicomponent vaccine
infant
child
adolescent
4CMenB vaccine
guidelines for drug use
antibiotic therapy
meningococcal vaccines

---
https://www.ema.europa.eu/medicines/human/EPAR/Bexsero
2013
false
United Kingdom
English
French
4CMenB vaccine
antibiotic therapy
meningococcus B, multicomponent vaccine
meningococcal vaccines
neisseria meningitidis, serogroup B
vaccination
infant
meningitis, meningococcal
meningococcal infections
sepsis
drug approval
europe
treatment outcome
injections, intramuscular
child
adult
adolescent
meningococcal infections
recombinant fusion proteins
recombinant proteins
NadA protein, neisseria meningitidis
factor H-binding protein, neisseria meningitidis
porin protein, neisseria
bacterial outer membrane proteins
antigens, bacterial
vaccines, synthetic
drug interactions
package leaflet
summary of product characteristics
drug evaluation
syndication feed
porins
bacterial proteins
adhesins, bacterial
meningococcal vaccines
meningococcal vaccines

---
http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=386
http://www.hcsp.fr/Explore.cgi/Telecharger?NomFichier=hcspr20131025_vaccmeningocoqueBBexsero.pdf
http://www.hcsp.fr/Explore.cgi/Telecharger?NomFichier=hcspr20131025_vaccmeningocoqueBBexseroann1.pdf
http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=399
2013
false
France
French
meningococcal vaccines
meningococcal infections
neisseria meningitidis, serogroup B
public health guidelines
infant
adolescent
child
adult
meningococcal vaccines
meningococcal vaccines
algorithms
technical report
meningococcus B, multicomponent vaccine
4CMenB vaccine
antibiotic therapy
meningococcal vaccines

---